ProShares fund tracks the performance of the Nasdaq Biotechnology Index.
9 reports, 2 independent
Updated Aug 30
Gone quiet
- Reports
- 9
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ProShares fund tracks the performance of the Nasdaq Biotechnology Index.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.ProShares ETF is linked to the Nasdaq index.1 source
ProShares launched an inverse daily performance fund tied to the NASDAQ-100 Index.1 source
ProShares fund tracks Nasdaq Biotechnology Index performance.1 source
Keep exploring
The entities involved
Related events
- A ProShares fund began tracking the performance of the US large-cap stock market.
- CEOs of participating biotech companies highlighted milestones and catalysts for investors on Nasdaq.
- The biotech sector relies on market infrastructure for raising capital.
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
Coverage
Newest first; wire copies grouped- tickerreport.com
- tickerreport.com
- dailypolitical.com
- tickerreport.com
- tickerreport.com
- tickerreport.com
- tickerreport.com